Role of Cytokines (IL-17 and IL-33), FGF-18, and WNT-5 in the Pathogenesis of Patients with Established Type II Diabetes

Authors

  • Przha Fadhil Mohammed Department of Basic Medical Sciences, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq. Author
  • Kawa Abdulla Muhammed Amin Department of Basic Medical Sciences, College of Medicine, University of Sulaimani, Kurdistan Region, Iraq. & Department of Medical Science, Respiratory Medicine, and Allergology, Uppsala University and University Hospital, Uppsala, Sweden. Author

DOI:

https://doi.org/10.17656/jzs.10949

Keywords:

Biomarkers, diabetes mellitus, pathogenesis, case-control comparative study, correlations

Abstract

Background: Biomarker investigation is important to detect the presence/severity of hyperglycemia, implying diabetes/pre-diabetes, or over time, as a risk factor for diabetic retinopathy, nephropathy, and other vascular complications related to diabetes.

 

Objectives: To determine the role and level of certain cytokines, FGF-18, and WNT5A in the serum of diabetic patients.

 

Patients and Methods: A case-control comparative study was conducted on 50 healthy individuals and 100 diabetic patients. Then; a validated questionnaire was used to collect the participants’ data. Next, participants’ serum level of IL-17, IL-33, FGF-18, and WNT5A was determined using the ELISA technique and the blood level of glycated hemoglobin (HbA1C).

 

Results: A highly significant difference in the levels of HbA1C and FGF-18 and a significant difference in levels of IL-17 and IL-33, with no significant difference in WNT-5A level, were seen between the studied groups. There was no significant difference between the biomarkers level and each gender, age, BMI, and duration of DM in the patients (p>0.05). A positive correlation was observed between the number of symptoms in the patients and levels of IL-17 (p=0.003) and IL-33 (p=0.018). Also, a positive correlation between IL-17 and IL33 (Rho=0.874, p<0.001), IL-17 and FGF-18 (p=0.023), as well as between IL-33 and FGF-18 (p=0.041) were seen.

 

Conclusion: It is realized that IL-17, IL33, and FGF-18 expression are directly related to DM, Additionally, a positive correlation between most biomarkers was seen. The detection of the cytokines’ levels and their relations with diabetic will affect the diagnosis, knowledge about the disease immunology, and thereafter effects on the treatments of patients with diabetic depending on our findings.

References

Lyons, T.J. and A. Basu, (2012). Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. DOI: https://doi.org/10.1016/j.trsl.2012.01.009

Translational Research, 159(4): p. 303-312.

Nauck, M.A. and J.J. Meier, (2020). GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet? The DOI: https://doi.org/10.1016/S2213-8587(20)30043-7

Lancet Diabetes & Endocrinology, 8(4): p. 262-264.

Zimmet, P., et al., (2016). Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nature DOI: https://doi.org/10.1038/nrendo.2016.105

Reviews Endocrinology, 12(10): p. 616-622.

Chung, W.K., et al., (2020). Precision medicine in diabetes: a consensus report from the American Diabetes DOI: https://doi.org/10.2337/dci20-0022

Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 43(7): p.

-1635.

Seferović, P., et al., (2022). Biomarkers for predicting heart failure and cardiovascular events in patients

with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of

Cardiology. European Journal of Heart Failure, 24(7): p. 1162-1170.

Shruthi, S., et al., (2016). Increased serum levels of novel T cell cytokines IL-33, IL-9 and IL-17 in subjects DOI: https://doi.org/10.1016/j.cyto.2016.07.007

with type-1 diabetes. Cytokine, 86: p. 6-9.

Mahmoud, B., et al., (2022). The relationship between B-cell lymphoma 2, interleukin-1β, interleukin-17, DOI: https://doi.org/10.1007/s11033-022-07221-7

and interleukin-33 and the development of diabetic nephropathy. Molecular Biology Reports, 49(5): p. 3803-

Murugaiyan, K., et al., (2023). Role of FGF-18 in Bone Regeneration. Journal of Functional Biomaterials, DOI: https://doi.org/10.3390/jfb14010036

(1): p. 36.

Shah, R., et al., (2023). Identification of Wnt receptors involved in Wnt-5a stimulation of diabetic corneal

epithelial wound healing. Investigative Ophthalmology & Visual Science, 64(8): p. 3106-3106.

Pigeyre, M. et al., (2023). Identifying blood biomarkers for type 2 diabetes subtyping: a report from the DOI: https://doi.org/10.1007/s00125-023-05887-7

ORIGIN trial. Diabetologia, 66(6): p. 1045-1051.

Sangar, M., et al., (2023). Microbial prevalence and outcome of diabetic foot ulcers in patient’s candidates

for minor surgical interventions. Journal of Zankoy Sulaimani-Part A, 25(1): p. 93-104.

Pedras, S., R. Carvalho, and M.d.G. Pereira, (2016). Sociodemographic and clinical characteristics of

patients with diabetic foot ulcer. Revista da Associação Médica Brasileira, 62: p. 171-178.

Stojanović, M., et al., (2018). Impact of sociodemographic characteristics and long-term complications on

quality of life in patients with diabetes mellitus. Central European Journal of Public Health, 26(2): p. 104-110.

Jeong, S.U., et al., (2010). Clinical characteristics of type 2 diabetes patients according to family history DOI: https://doi.org/10.4093/kdj.2010.34.4.222

of diabetes. Korean Diabetes Journal, 34(4): p. 222-228.

Pereira, M.J. et al., (2023). Interleukin-33 inhibits glucose uptake in human adipocytes and its expression

in adipose tissue is elevated in insulin resistance and type 2 diabetes. Cytokine, 161: p. 156080. DOI: https://doi.org/10.1016/j.cyto.2022.156080

Hasan, A., et al., (2019). Association between adipose tissue interleukin-33 and immunometabolic markers DOI: https://doi.org/10.1155/2019/7901062

in individuals with varying degrees of glycemia. Disease Markers, p. 1-17.

Bosnic, Z., et al. (2021). Clustering Inflammatory Markers with Sociodemographic and Clinical

Characteristics of Patients with Diabetes Type 2 Can Support Family Physicians’ Clinical Reasoning by

Reducing Patients’ Complexity. in Healthcare. MDPI.

Deng, J., et al., (2021). The multiple roles of fibroblast growth factor in diabetic nephropathy. Journal of DOI: https://doi.org/10.2147/JIR.S334996

Inflammation Research, 14: p. 5273-5290.

Wang, H., et al., (2022). The wnt signaling pathway in diabetic nephropathy. Frontiers in Cell and DOI: https://doi.org/10.3389/fcell.2021.701547

Developmental Biology, 9: p. 701547.

Jasim, H.S., et al., (2022). Comparative Study of New Biomarkers in Iraqi DM2 with and without

Complications. Reports of Biochemistry & Molecular Biology, 11(3): p. 400-404.

Published

2023-12-20

How to Cite

Role of Cytokines (IL-17 and IL-33), FGF-18, and WNT-5 in the Pathogenesis of Patients with Established Type II Diabetes. (2023). Journal of Zankoy Sulaimani - Part A, 25(2), 11. https://doi.org/10.17656/jzs.10949

Most read articles by the same author(s)